Lifeward (LFWD) Free Cash Flow (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.61% |
| Dec 31, 2025 | 8.55% |
| Sep 30, 2025 | 0.74% |
| Jun 30, 2025 | 29.16% |
| Mar 31, 2025 | -38.70% |
| Dec 31, 2024 | 10.99% |
| Sep 30, 2024 | 20.62% |
| Jun 30, 2024 | 26.80% |
| Mar 31, 2024 | -68.16% |
| Dec 31, 2023 | 38.72% |
| Sep 30, 2023 | -112.38% |
| Jun 30, 2023 | 33.00% |
| Mar 31, 2023 | -33.73% |
| Dec 31, 2022 | 15.08% |
| Sep 30, 2022 | -25.08% |
| Jun 30, 2022 | 35.49% |
| Mar 31, 2022 | -120.93% |
| Dec 31, 2021 | -0.19% |
| Sep 30, 2021 | 18.59% |
| Jun 30, 2021 | 0.41% |
| Mar 31, 2021 | -29.45% |
| Dec 31, 2020 | 7.45% |
| Sep 30, 2020 | 16.95% |
| Jun 30, 2020 | 26.48% |
| Mar 31, 2020 | -20.70% |
| Dec 31, 2019 | -10.25% |
| Sep 30, 2019 | 11.72% |
| Jun 30, 2019 | 12.93% |
| Mar 31, 2019 | -62.95% |
| Dec 31, 2018 | 16.13% |
| Sep 30, 2018 | 23.01% |
| Jun 30, 2018 | 19.58% |
| Mar 31, 2018 | 7.30% |
| Dec 31, 2017 | 7.21% |
| Sep 30, 2017 | -12.82% |
| Jun 30, 2017 | 14.24% |
| Mar 31, 2017 | 8.38% |
| Dec 31, 2016 | 1.63% |
| Sep 30, 2016 | 2.08% |
| Jun 30, 2016 | 3.17% |
| Mar 31, 2016 | 3.13% |
| Dec 31, 2015 | -223.25% |
| Sep 30, 2015 | 0.70% |
| Jun 30, 2015 | 189.96% |
| Mar 31, 2015 | -140.54% |
| Dec 31, 2014 | -146.55% |
| Sep 30, 2014 | 53.16% |
| Dec 31, 2013 | -223.12% |